36 min listen
Optimizing Treatment Pathways in CLL and MCL: Evaluating and Applying Recent Data on BTK Inhibitors
Optimizing Treatment Pathways in CLL and MCL: Evaluating and Applying Recent Data on BTK Inhibitors
ratings:
Length:
37 minutes
Released:
Mar 29, 2024
Format:
Podcast episode
Description
Do you struggle with how to optimally interpret chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL)? Hear from the experts. Credit available for this activity expires: 3/29/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000542?ecd=bdc_podcast_libsyn_mscpedu
Released:
Mar 29, 2024
Format:
Podcast episode
Titles in the series (100)
Acute Myeloid Leukemia Beyond FLT3 and IDH: The Role of Non-Targetable Driver Mutations: Do you understand the role of non-targetable driver mutations in the management of acute myeloid leukemia (AML)? Credit available for this activity expires: 5/1/2024 Earn Credit / Learning Objectives & Disclosures: by Keeping Current CME